Filing Details
- Accession Number:
- 0001209191-12-024645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-27 15:30:29
- Reporting Period:
- 2012-04-26
- Filing Date:
- 2012-04-27
- Filing Date Changed:
- 2012-04-27
- Accepted Time:
- 2012-04-27 16:30:29
- Original Submission Date:
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235118 | S Randall Livingston | Stanford University Bldg 60, Main Quadrangle Stanford CA 94305 |
Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings |
|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-26 | 2,000 | $1.33 | 8,149 |
| Common Stock | Disposition | 2012-04-26 | 2,000 | $28.21 | 6,149 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2012-04-26 | 2,000 | $0.00 | 2,000 | $1.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,346 | 2014-10-06 | No | 4 | M | Direct |
Footnotes
- This sale of common stock was effected persuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 18, 2011.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $28.05 to $28.42.
- The option became exercisable as to 25% of the shares on October 6, 2005,and became exercisable as to 1/48th of the shares each full month thereafter.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!
